Supreme Court weighs in on Purdue Pharma’s bankruptcy, with an eye toward the Sacklers and helping opioid victimsnews2023-12-04T19:26:25+00:00December 4th, 2023|Endpoints News|
Health insurance members stand to lose out if Cigna and Humana finalize a megamerger, experts saynews2023-12-04T18:21:00+00:00December 4th, 2023|Endpoints News|
House committee investigates FDA’s handling of common nasal decongestant as efficacy questions loomnews2023-12-04T16:39:29+00:00December 4th, 2023|Endpoints News|
EyePoint’s stock soars over 200% as wet AMD asset matches Regeneron’s Eylea in PhII trialnews2023-12-04T16:19:13+00:00December 4th, 2023|Endpoints News|
Ideaya partners with Gilead; Lilly extends offer for Point; Theseus lets go of CEO, CMOnews2023-12-04T16:15:24+00:00December 4th, 2023|Endpoints News|
Atsena touts one-year data for congenital eye disease therapy as it seeks partner for pivotal studynews2023-12-04T15:53:31+00:00December 4th, 2023|Endpoints News|
Abbisko signs $70M upfront deal with Merck KGaA for PhIII cancer drugnews2023-12-04T14:56:26+00:00December 4th, 2023|Endpoints News|
WuXi Biologics’ stock slides by 24% as manufacturing business slows amid biotech downturnnews2023-12-04T12:02:55+00:00December 4th, 2023|Endpoints News|
Novartis unveils new brand identity after Sandoz spinoffnews2023-12-04T12:00:42+00:00December 4th, 2023|Endpoints News|
UCSF scientists aim to unravel autism with brain organoids and AInews2023-12-04T12:00:26+00:00December 4th, 2023|Endpoints News|
